{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:25:43Z","timestamp":1788326743319,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Entrega Inc."},{"name":"Otis Williams Fellowship"},{"name":"Santa Barbara Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jconrel.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T23:16:56Z","timestamp":1368487016000},"page":"541-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine"],"prefix":"10.1016","volume":"172","author":[{"given":"Vivek","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishit","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mitragotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19\u201320","key":"10.1016\/j.jconrel.2013.05.002_bb0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i2.20","article-title":"Oral delivery of proteins: progress and prognostication","volume":"19","author":"Shah","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"1-2","key":"10.1016\/j.jconrel.2013.05.002_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schnurch","year":"1998","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2013.05.002_bb0020","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2013.05.002_bb0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11095-012-0913-3","article-title":"Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery","volume":"30","author":"Deat-Laine","year":"2013","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2013.05.002_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2010.08.007","article-title":"Cyclodextrin complexed insulin encapsulated hydrogel microparticles: an oral delivery system for insulin","volume":"147","author":"Sajeesh","year":"2010","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2013.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2012.06.054","article-title":"Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation","volume":"436","author":"Zhang","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/02652048.2012.665091","article-title":"Evaluation of microemulsion and liposomes as carriers for oral delivery of transforming growth factor alpha in rats","volume":"29","author":"Celebi","year":"2012","journal-title":"J. Microencapsul."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2011.05.066","article-title":"Oral peptide delivery by tetraether lipid liposomes","volume":"415","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2012.11.002","article-title":"Oral drug delivery systems using chemical conjugates or physical complexes","author":"Al-Hilal","year":"2013","journal-title":"Adv. Drug Delivery Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0060","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cmdc.201200461","article-title":"Synthesis, Characterization and Pharmacodynamics of Vitamin-B(12) -Conjugated Glucagon-Like Peptide-1","volume":"8","author":"Clardy-James","year":"2013","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Adv. Drug Delivery Rev."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2005.01.022","article-title":"Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium","volume":"294","author":"Salamat-Miller","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425240903338758","article-title":"Chemical permeation enhancers for transbuccal drug delivery","volume":"7","author":"Hassan","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.jconrel.2013.05.002_bb0080","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/17425247.2011.607437","article-title":"Nasal route: an alternative approach for antiemetic drug delivery","volume":"8","author":"Ozsoy","year":"2011","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0085","first-page":"495","article-title":"Permeation enhancers in the transmucosal delivery of macromolecules","volume":"61","author":"Sharma","year":"2006","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.jconrel.2013.05.002_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/03639040903117348","article-title":"Critical evaluation of permeation enhancers for oral mucosal drug delivery","volume":"36","author":"Sohi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11095-006-0204-y","article-title":"Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells","volume":"23","author":"Bourdet","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archoralbio.2011.06.013","article-title":"Potential uses of human salivary protein and peptide analysis in the diagnosis of disease","volume":"57","author":"Al Kawas","year":"2012","journal-title":"Arch. Oral Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6865(97)00018-6","article-title":"Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate","volume":"72","author":"Hosny","year":"1997","journal-title":"Pharm. Acta Helv."},{"issue":"8","key":"10.1016\/j.jconrel.2013.05.002_bb0115","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11095-007-9488-9","article-title":"Safe and effective permeation enhancers for oral drug delivery","volume":"25","author":"Whitehead","year":"2008","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0120","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s11095-008-9542-2","article-title":"Mechanistic analysis of chemical permeation enhancers for oral drug delivery","volume":"25","author":"Whitehead","year":"2008","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2013.05.002_bb0125","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1021\/nn302687n","article-title":"Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1","volume":"6","author":"Han","year":"2012","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2013.05.002_bb0130","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/10611860400020191","article-title":"Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin","volume":"13","author":"Yang","year":"2005","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1520-6017(200101)90:1<38::AID-JPS5>3.0.CO;2-3","article-title":"Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo","volume":"90","author":"Thanou","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2013.05.002_bb0145","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/js9800735","article-title":"Enhancement of intestinal model compound transport by DS-1, a modified Quillaja saponin","volume":"87","author":"Chao","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.12.014","article-title":"Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer","volume":"354","author":"Kavimandan","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2013.05.002_bb0155","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/17425247.2011.604311","article-title":"Solid lipid nanoparticles: an oral bioavailability enhancer vehicle","volume":"8","author":"Harde","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpb.2004.03.023","article-title":"Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs","volume":"58","author":"van der Merwe","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"15","key":"10.1016\/j.jconrel.2013.05.002_bb0165","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.jconrel.2013.05.002_bb0170","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.jconrel.2013.05.002_bb0175","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1211\/0022357991776976","article-title":"Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside","volume":"51","author":"Uchiyama","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0180","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-3565(25)38767-7","article-title":"In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine","volume":"269","author":"Hochman","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1567201053586001","article-title":"Oral delivery of insulin with the eligen technology: mechanistic studies","volume":"2","author":"Malkov","year":"2005","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/02652040410001653786","article-title":"Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats","volume":"21","author":"Qi","year":"2004","journal-title":"J. Microencapsul."},{"issue":"5","key":"10.1016\/j.jconrel.2013.05.002_bb0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/17425247.3.5.685","article-title":"Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET","volume":"3","author":"Leonard","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-5491.2004.01160.x","article-title":"A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects","volume":"21","author":"Kidron","year":"2004","journal-title":"Diabet. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2013.05.002_bb0205","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1359\/jbmr.2002.17.8.1478","article-title":"Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers","volume":"17","author":"Buclin","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"16","key":"10.1016\/j.jconrel.2013.05.002_bb0210","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.98.16.1610","article-title":"Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans","volume":"98","author":"Baughman","year":"1998","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jconrel.2013.05.002_bb0215","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1046\/j.1538-7836.2003.00340.x","article-title":"Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty","volume":"1","author":"Berkowitz","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12248-011-9307-4","article-title":"Absorption enhancers: applications and advances","volume":"14","author":"Aungst","year":"2012","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0230","doi-asserted-by":"crossref","first-page":"e57136","DOI":"10.1371\/journal.pone.0057136","article-title":"Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0235","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/js9504604","article-title":"Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells","volume":"85","author":"Tomita","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2013.05.002_bb0245","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.2042-7158.1998.tb03319.x","article-title":"Cytotoxicity of absorption enhancers in Caco-2 cell monolayers","volume":"50","author":"Sakai","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3565(24)37802-4","article-title":"Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells","volume":"287","author":"Duizer","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2013.05.002_bb0255","first-page":"32","article-title":"Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro","volume":"9","author":"Tirumalasetty","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0260","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0022-3565(25)39367-5","article-title":"Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy","volume":"267","author":"Hurni","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2013.05.002_bb0265","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/03639049809085625","article-title":"Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate","volume":"24","author":"Hosny","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(02)00024-8","article-title":"Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs","volume":"237","author":"Hosny","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2013.05.002_bb0275","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"issue":"4 Pt 1","key":"10.1016\/j.jconrel.2013.05.002_bb0280","doi-asserted-by":"crossref","first-page":"C630","DOI":"10.1152\/ajpcell.1990.258.4.C630","article-title":"Potassium conductances in tracheal epithelium activated by secretion and cell swelling","volume":"258","author":"Butt","year":"1990","journal-title":"Am. J. Physiol."},{"issue":"18","key":"10.1016\/j.jconrel.2013.05.002_bb0285","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0024-3205(92)90540-6","article-title":"Niflumic and flufenamic acids are potent inhibitors of chloride secretion in mammalian airway","volume":"51","author":"Chao","year":"1992","journal-title":"Life Sci."},{"issue":"53","key":"10.1016\/j.jconrel.2013.05.002_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/newbio235009a0","article-title":"Route of passive ion permeation in epithelia","volume":"235","author":"Fromter","year":"1972","journal-title":"Nat. New Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0295","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1023\/A:1011908128045","article-title":"Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways","volume":"15","author":"Swaan","year":"1998","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0300","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1018819012405","article-title":"Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT)","volume":"16","author":"Sinko","year":"1999","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.12.029","article-title":"Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid","volume":"294","author":"Imai","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2013.05.002_bb0310","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2005.05.016","article-title":"Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts","volume":"106","author":"Song","year":"2005","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.05.002_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-5173(95)04395-0","article-title":"Improvement of intestinal absorption of human calcitonin by chemical modification with fatty acids: synergistic effects of acylation and absorption enhancers","volume":"134","author":"Fujita","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2013.05.002_bb0320","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2009.07.011","article-title":"Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4\u20135","key":"10.1016\/j.jconrel.2013.05.002_bb0325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejps.2013.01.009","article-title":"Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer","volume":"48","author":"Petersen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0330","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10717544.2011.570807","article-title":"Thiolated polycarbophil\/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate","volume":"18","author":"Perera","year":"2011","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2013.05.002_bb0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2003.05.001","article-title":"Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer\/GSH systems","volume":"93","author":"Bernkop-Schnurch","year":"2003","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0340","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2003.10.045","article-title":"Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins","volume":"56","author":"Fasano","year":"2004","journal-title":"Adv. Drug Delivery Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2013.05.002_bb0345","first-page":"481","article-title":"Structure and function of tight junctions. Role in intestinal barrier","volume":"31","author":"Gasbarrini","year":"1999","journal-title":"Ital. J. Gastroenterol. Hepatol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:29:50Z","timestamp":1759159790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168365913002484"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}